Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score-Reference-Cited by-同舟云学术

Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score

Published:2017-11-30 Issue:67 Volume:8 Page:111309-111317
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Yongmei¹²,Deng Lei¹,Zhou Xiaojuan¹,Gong Youling¹,Xu Yong¹,Zhou Lin¹,Wan Jin¹,Zou Bingwen¹,Wang Yongsheng¹,Zhu Jiang¹,Ding Zhenyu¹,Peng Feng¹,Huang Meijuan¹,Ren Li¹,Lautenschlaeger Tim²,Kong Feng-Ming (Spring)²,Lu You¹

Affiliation:

1. Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

2. Department of Radiation Oncology, IU Simon Cancer Center, IU School of Medicine, Indiana University, Indianapolis, IN, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review;Advances in Therapy;2024-03-21

2. First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis;BMC Cancer;2023-10-30

3. Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases;Brain Sciences;2023-09-03

4. Survival outcomes of NSCLC patients with brain metastases stratified by Lung- molGPA and application and timing of cranial radiotherapy;2023-07-24

5. Survival outcomes of NSCLC patients with brain metastases stratified by Lung- molGPA and application and timing of cranial radiotherapy;2023-06-30